Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Image-Guided Biopsy | 5 | 2019 | 185 | 0.82 | Why? |
| Pulmonary Ventilation | 1 | 2020 | 152 | 0.74 | Why? |
| Mediastinal Neoplasms | 1 | 2019 | 57 | 0.73 | Why? |
| Cone-Beam Computed Tomography | 4 | 2019 | 118 | 0.71 | Why? |
| Radiographic Image Enhancement | 1 | 2018 | 89 | 0.68 | Why? |
| Mediastinum | 1 | 2017 | 122 | 0.66 | Why? |
| Radiography, Thoracic | 5 | 2021 | 5486 | 0.61 | Why? |
| Multidetector Computed Tomography | 1 | 2019 | 307 | 0.60 | Why? |
| Computed Tomography Angiography | 2 | 2020 | 2153 | 0.51 | Why? |
| Thoracic Surgical Procedures | 1 | 2019 | 504 | 0.50 | Why? |
| Imaging, Three-Dimensional | 1 | 2018 | 680 | 0.49 | Why? |
| Tomography, X-Ray Computed | 12 | 2021 | 25144 | 0.49 | Why? |
| Printing, Three-Dimensional | 1 | 2018 | 624 | 0.47 | Why? |
| Mycobacterium Infections, Nontuberculous | 3 | 2019 | 167 | 0.44 | Why? |
| Pulmonary Embolism | 2 | 2020 | 4775 | 0.43 | Why? |
| Lung Diseases | 3 | 2019 | 2361 | 0.41 | Why? |
| Virtual Reality | 1 | 2018 | 640 | 0.40 | Why? |
| Lung Neoplasms | 4 | 2020 | 3228 | 0.35 | Why? |
| Hemoptysis | 2 | 2018 | 172 | 0.30 | Why? |
| Lung | 7 | 2021 | 31049 | 0.30 | Why? |
| Thorax | 4 | 2019 | 1873 | 0.29 | Why? |
| Venous Thrombosis | 1 | 2020 | 2739 | 0.29 | Why? |
| Diagnostic Errors | 2 | 2019 | 865 | 0.24 | Why? |
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2021 | 869 | 0.24 | Why? |
| Contrast Media | 2 | 2018 | 1011 | 0.23 | Why? |
| Bronchi | 2 | 2018 | 1048 | 0.22 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.22 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.21 | Why? |
| Pleura | 2 | 2018 | 178 | 0.20 | Why? |
| Nontuberculous Mycobacteria | 2 | 2017 | 114 | 0.20 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.20 | Why? |
| Rats, Inbred F344 | 1 | 2018 | 33 | 0.19 | Why? |
| Thymoma | 1 | 2019 | 47 | 0.19 | Why? |
| Thymus Neoplasms | 1 | 2019 | 69 | 0.18 | Why? |
| Biopsy, Fine-Needle | 1 | 2019 | 274 | 0.18 | Why? |
| Pleural Neoplasms | 1 | 2018 | 71 | 0.18 | Why? |
| Phantoms, Imaging | 1 | 2018 | 146 | 0.18 | Why? |
| Pleural Diseases | 1 | 2018 | 68 | 0.17 | Why? |
| Signal-To-Noise Ratio | 1 | 2018 | 217 | 0.17 | Why? |
| Clarithromycin | 1 | 2017 | 112 | 0.17 | Why? |
| Multiple Pulmonary Nodules | 1 | 2018 | 115 | 0.16 | Why? |
| Tuberculosis, Pulmonary | 2 | 2017 | 1171 | 0.16 | Why? |
| Nausea | 1 | 2018 | 457 | 0.14 | Why? |
| Rabbits | 1 | 2018 | 1171 | 0.14 | Why? |
| Lymphoma | 1 | 2019 | 522 | 0.13 | Why? |
| Adiposity | 1 | 2017 | 329 | 0.13 | Why? |
| Sputum | 2 | 2019 | 1720 | 0.13 | Why? |
| Vomiting | 1 | 2018 | 722 | 0.12 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Fasting | 1 | 2018 | 555 | 0.12 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 433 | 0.12 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.12 | Why? |
| Republic of Korea | 3 | 2021 | 5858 | 0.11 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2018 | 595 | 0.11 | Why? |
| Sensitivity and Specificity | 4 | 2020 | 22971 | 0.11 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2018 | 665 | 0.11 | Why? |
| Bronchoscopy | 1 | 2019 | 991 | 0.11 | Why? |
| Aged | 16 | 2021 | 215776 | 0.10 | Why? |
| Rats | 1 | 2018 | 2764 | 0.10 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.10 | Why? |
| Age Distribution | 1 | 2019 | 3567 | 0.10 | Why? |
| Anaphylaxis | 1 | 2019 | 940 | 0.10 | Why? |
| Male | 17 | 2021 | 367725 | 0.10 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.09 | Why? |
| Humans | 26 | 2021 | 930598 | 0.09 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.09 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.09 | Why? |
| Female | 17 | 2021 | 380317 | 0.09 | Why? |
| Biopsy, Needle | 2 | 2018 | 303 | 0.08 | Why? |
| Diagnosis, Differential | 2 | 2019 | 7220 | 0.08 | Why? |
| Hypersensitivity | 1 | 2018 | 1137 | 0.08 | Why? |
| Lung Diseases, Interstitial | 1 | 2018 | 1476 | 0.08 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.08 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.06 | Why? |
| Sex Factors | 1 | 2019 | 11014 | 0.06 | Why? |
| Adult | 10 | 2020 | 244371 | 0.05 | Why? |
| Prospective Studies | 4 | 2019 | 43301 | 0.05 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.05 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.05 | Why? |
| Iopamidol | 1 | 2018 | 19 | 0.05 | Why? |
| Triiodobenzoic Acids | 1 | 2018 | 12 | 0.05 | Why? |
| Iohexol | 1 | 2018 | 42 | 0.05 | Why? |
| Fluoroscopy | 1 | 2018 | 140 | 0.04 | Why? |
| Drug Administration Routes | 1 | 2018 | 106 | 0.04 | Why? |
| Drug Resistance, Bacterial | 2 | 2017 | 1414 | 0.04 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.04 | Why? |
| Age Factors | 1 | 2019 | 21039 | 0.04 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.04 | Why? |
| Seoul | 1 | 2017 | 206 | 0.04 | Why? |
| Abdominal Fat | 1 | 2017 | 43 | 0.04 | Why? |
| Odds Ratio | 2 | 2019 | 5861 | 0.04 | Why? |
| Tuberculin Test | 1 | 2017 | 141 | 0.04 | Why? |
| Iodine | 1 | 2018 | 116 | 0.04 | Why? |
| Radiography, Interventional | 1 | 2018 | 158 | 0.04 | Why? |
| Anthropometry | 1 | 2017 | 233 | 0.04 | Why? |
| Leptin | 1 | 2017 | 141 | 0.04 | Why? |
| Bronchoalveolar Lavage | 1 | 2019 | 603 | 0.04 | Why? |
| Child | 2 | 2020 | 70012 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2020 | 1999 | 0.03 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2020 | 1425 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.03 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.03 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Animals | 1 | 2018 | 78931 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2019 | 2643 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.02 | Why? |
| Risk Factors | 3 | 2019 | 71621 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2018 | 48226 | 0.01 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
Yoon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(127)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(95)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_